PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-3.99%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-3.25%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-19.17%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-27.13%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-25.66%
Negative net income growth while 9843.T stands at 6.33%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-25.65%
Negative EPS growth while 9843.T is at 6.26%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-25.65%
Negative diluted EPS growth while 9843.T is at 6.26%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-0.00%
Share reduction while 9843.T is at 0.07%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.00%
Reduced diluted shares while 9843.T is at 0.07%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
5.51%
OCF growth of 5.51% while 9843.T is zero. Bruce Berkowitz would see if small gains can expand into a larger competitive lead.
5.51%
FCF growth of 5.51% while 9843.T is zero. Bruce Berkowitz would see if modest improvements in free cash can accelerate further.
27.44%
10Y revenue/share CAGR under 50% of 9843.T's 164.71%. Michael Burry would suspect a lasting competitive disadvantage.
49.80%
5Y revenue/share CAGR similar to 9843.T's 49.45%. Walter Schloss might see both companies benefiting from the same mid-term trends.
23.09%
3Y revenue/share CAGR at 50-75% of 9843.T's 32.93%. Martin Whitman would question if the firm lags behind competitor innovations.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
13.42%
Below 50% of 9843.T's 238.49%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
53.29%
5Y net income/share CAGR at 75-90% of 9843.T's 64.22%. Bill Ackman would advocate improvements to match competitor’s profit expansion.
29.45%
Below 50% of 9843.T's 59.68%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
143.96%
Below 50% of 9843.T's 299.47%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
100.32%
5Y equity/share CAGR 1.25-1.5x 9843.T's 84.61%. Bruce Berkowitz confirms if reinvested profits or buybacks explain the superior buildup.
49.44%
3Y equity/share CAGR similar to 9843.T's 47.41%. Walter Schloss sees both having parallel profitability or reinvestment over 3 years.
112.50%
10Y dividend/share CAGR at 50-75% of 9843.T's 224.44%. Martin Whitman suspects the firm lags in returning cash to shareholders over the decade.
88.89%
5Y dividend/share CAGR 1.25-1.5x 9843.T's 62.22%. Bruce Berkowitz verifies that high dividend hikes remain sustainable, not a sign of over-distribution.
70.00%
3Y dividend/share CAGR above 1.5x 9843.T's 35.19%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
29.48%
Our AR growth while 9843.T is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
10.13%
Inventory growth well above 9843.T's 4.15%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
1.50%
Positive asset growth while 9843.T is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
2.47%
50-75% of 9843.T's 3.71%. Martin Whitman suspects weaker earnings or capital allocation vs. the competitor.
-8.57%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
3.12%
We expand SG&A while 9843.T cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.